• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 APP 的症状追踪,使用机器学习优化 SARS-CoV-2 检测策略。

App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning.

机构信息

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Instituto Tecgraf, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

出版信息

PLoS One. 2021 Mar 25;16(3):e0248920. doi: 10.1371/journal.pone.0248920. eCollection 2021.

DOI:10.1371/journal.pone.0248920
PMID:33765050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993758/
Abstract

BACKGROUND

Tests are scarce resources, especially in low and middle-income countries, and the optimization of testing programs during a pandemic is critical for the effectiveness of the disease control. Hence, we aim to use the combination of symptoms to build a predictive model as a screening tool to identify people and areas with a higher risk of SARS-CoV-2 infection to be prioritized for testing.

MATERIALS AND METHODS

We performed a retrospective analysis of individuals registered in "Dados do Bem," a Brazilian app-based symptom tracker. We applied machine learning techniques and provided a SARS-CoV-2 infection risk map of Rio de Janeiro city.

RESULTS

From April 28 to July 16, 2020, 337,435 individuals registered their symptoms through the app. Of these, 49,721 participants were tested for SARS-CoV-2 infection, being 5,888 (11.8%) positive. Among self-reported symptoms, loss of smell (OR[95%CI]: 4.6 [4.4-4.9]), fever (2.6 [2.5-2.8]), and shortness of breath (2.1 [1.6-2.7]) were independently associated with SARS-CoV-2 infection. Our final model obtained a competitive performance, with only 7% of false-negative users predicted as negatives (NPV = 0.93). The model was incorporated by the "Dados do Bem" app aiming to prioritize users for testing. We developed an external validation in the city of Rio de Janeiro. We found that the proportion of positive results increased significantly from 14.9% (before using our model) to 18.1% (after the model).

CONCLUSIONS

Our results showed that the combination of symptoms might predict SARS-Cov-2 infection and, therefore, can be used as a tool by decision-makers to refine testing and disease control strategies.

摘要

背景

检测资源稀缺,尤其是在中低收入国家,因此大流行期间优化检测计划对于疾病控制的有效性至关重要。因此,我们旨在使用症状组合建立预测模型作为筛查工具,以识别具有更高 SARS-CoV-2 感染风险的人群和地区,以便优先进行检测。

材料和方法

我们对在巴西基于应用程序的症状跟踪器“Dados do Bem”中注册的个体进行了回顾性分析。我们应用了机器学习技术,并提供了里约热内卢市的 SARS-CoV-2 感染风险图。

结果

从 2020 年 4 月 28 日至 7 月 16 日,有 337435 人通过该应用程序登记了他们的症状。其中,有 49721 名参与者接受了 SARS-CoV-2 感染检测,有 5888 人(11.8%)呈阳性。在自我报告的症状中,嗅觉丧失(OR[95%CI]:4.6 [4.4-4.9])、发热(2.6 [2.5-2.8])和呼吸急促(2.1 [1.6-2.7])与 SARS-CoV-2 感染独立相关。我们的最终模型表现出色,只有 7%的假阴性用户被预测为阴性(NPV=0.93)。该模型已被“Dados do Bem”应用程序采用,旨在优先为用户进行检测。我们在里约热内卢市进行了外部验证。我们发现,阳性结果的比例从使用模型前的 14.9%显著增加到使用模型后的 18.1%。

结论

我们的结果表明,症状组合可能预测 SARS-CoV-2 感染,因此可以作为决策者完善检测和疾病控制策略的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/21456480f8b4/pone.0248920.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/eaa59bc9dc48/pone.0248920.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/8de98e17b02b/pone.0248920.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/97bdf7bd5f89/pone.0248920.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/e6f14d445b18/pone.0248920.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/21456480f8b4/pone.0248920.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/eaa59bc9dc48/pone.0248920.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/8de98e17b02b/pone.0248920.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/97bdf7bd5f89/pone.0248920.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/e6f14d445b18/pone.0248920.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4bb/7993758/21456480f8b4/pone.0248920.g005.jpg

相似文献

1
App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning.基于 APP 的症状追踪,使用机器学习优化 SARS-CoV-2 检测策略。
PLoS One. 2021 Mar 25;16(3):e0248920. doi: 10.1371/journal.pone.0248920. eCollection 2021.
2
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.在六个国家数字监测平台上,与 SARS-CoV-2 检测呈阳性相关的嗅觉丧失、味觉丧失和其他类似 COVID-19 的症状:一项观察性研究。
Lancet Digit Health. 2021 Sep;3(9):e577-e586. doi: 10.1016/S2589-7500(21)00115-1. Epub 2021 Jul 22.
3
App-Based Tracking of Self-Reported COVID-19 Symptoms: Analysis of Questionnaire Data.基于应用程序的自我报告新冠病毒症状追踪:问卷数据分析
J Med Internet Res. 2020 Sep 9;22(9):e21956. doi: 10.2196/21956.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.社区中 COVID-19 的预测症状:超过 100 万人的 REACT-1 研究。
PLoS Med. 2021 Sep 28;18(9):e1003777. doi: 10.1371/journal.pmed.1003777. eCollection 2021 Sep.
6
Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.安大略省多伦多市接受门诊检测人群中新发嗅觉丧失与 SARS-CoV-2 检测阳性之间的关联:一项回顾性横断面研究。
CMAJ Open. 2021 Dec 7;9(4):E1134-E1140. doi: 10.9778/cmajo.20210085. Print 2021 Oct-Dec.
7
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.基于社区人群的 SARS-CoV-2 感染相关症状和症状群:全州范围的流行病学研究结果。
PLoS One. 2021 Mar 24;16(3):e0241875. doi: 10.1371/journal.pone.0241875. eCollection 2021.
8
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.检测时的 COVID-19 症状与 SARS-CoV-2 检测门诊患者的阳性率之间的关系。
PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021.
9
Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study.利用自我报告症状在英国早期检测 COVID-19:一项大规模、前瞻性、流行病学监测研究。
Lancet Digit Health. 2021 Sep;3(9):e587-e598. doi: 10.1016/S2589-7500(21)00131-X. Epub 2021 Jul 29.
10
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.

引用本文的文献

1
Machine Learning and Artificial Intelligence for Infectious Disease Surveillance, Diagnosis, and Prognosis.用于传染病监测、诊断和预后的机器学习与人工智能
Viruses. 2025 Jun 23;17(7):882. doi: 10.3390/v17070882.
2
Does viral circulation in slums have a global impact? The lesson learned from SARS-CoV-2 circulation in , Rio de Janeiro, Brazil.贫民窟中的病毒传播会产生全球影响吗?从巴西里约热内卢SARS-CoV-2的传播中吸取的教训。
Front Microbiol. 2025 Feb 12;16:1483895. doi: 10.3389/fmicb.2025.1483895. eCollection 2025.
3
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness.

本文引用的文献

1
Sociodemographic factors associated with COVID-19 in-hospital mortality in Brazil.与巴西 COVID-19 院内死亡率相关的社会人口学因素。
Public Health. 2021 Mar;192:15-20. doi: 10.1016/j.puhe.2021.01.005. Epub 2021 Jan 15.
2
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.巴西 25 万例 COVID-19 住院患者的特征:全国范围内数据的回顾性分析。
Lancet Respir Med. 2021 Apr;9(4):407-418. doi: 10.1016/S2213-2600(20)30560-9. Epub 2021 Jan 15.
3
Wearable sensor data and self-reported symptoms for COVID-19 detection.
社论:利用人工智能(AI)进行传染病监测及其在疫情和大流行防范中的作用。
Med Sci Monit. 2023 Jun 1;29:e941209. doi: 10.12659/MSM.941209.
4
Effectiveness of a multicomponent intervention to face the COVID-19 pandemic in Rio de Janeiro's favelas: difference-in-differences analysis.里约热内卢贫民窟应对 COVID-19 大流行的多组分干预措施的效果:差分分析。
BMJ Glob Health. 2023 May;8(5). doi: 10.1136/bmjgh-2022-009997.
5
Modern Machine-Learning Predictive Models for Diagnosing Infectious Diseases.现代机器学习预测模型在传染病诊断中的应用。
Comput Math Methods Med. 2022 Jun 9;2022:6902321. doi: 10.1155/2022/6902321. eCollection 2022.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.新型冠状病毒2019感染门诊患者的疾病进程及住院风险因素
Sci Rep. 2022 May 4;12(1):7249. doi: 10.1038/s41598-022-11103-0.
8
Prediction of SARS-CoV-2 infection with a Symptoms-Based model to aid public health decision making in Latin America and other low and middle income settings.基于症状模型预测新冠病毒感染,以协助拉丁美洲及其他低收入和中等收入地区的公共卫生决策。
Prev Med Rep. 2022 Jun;27:101798. doi: 10.1016/j.pmedr.2022.101798. Epub 2022 Apr 20.
9
Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna.维也纳未住院患者队列中与 COVID-19 感染相关的症状。
Wien Klin Wochenschr. 2022 May;134(9-10):344-350. doi: 10.1007/s00508-022-02028-9. Epub 2022 Apr 13.
10
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future.SARS-CoV-2 诊断检测方法的选择:未来的挑战和关键考虑因素。
Crit Rev Clin Lab Sci. 2022 Nov;59(7):445-459. doi: 10.1080/10408363.2022.2045250. Epub 2022 Mar 15.
可穿戴传感器数据和自我报告症状用于 COVID-19 检测。
Nat Med. 2021 Jan;27(1):73-77. doi: 10.1038/s41591-020-1123-x. Epub 2020 Oct 29.
4
Syndromic Surveillance Insights from a Symptom Assessment App Before and During COVID-19 Measures in Germany and the United Kingdom: Results From Repeated Cross-Sectional Analyses.症状评估应用程序在德国和英国 COVID-19 措施前后的综合征监测洞察:重复横断面分析结果。
JMIR Mhealth Uhealth. 2020 Oct 9;8(10):e21364. doi: 10.2196/21364.
5
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
6
Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing.大规模人群中 COVID-19 症状、行为和检测的纵向图谱绘制。
Nat Hum Behav. 2020 Sep;4(9):972-982. doi: 10.1038/s41562-020-00944-2. Epub 2020 Aug 26.
7
Estimating the efficacy of symptom-based screening for COVID-19.评估基于症状的新型冠状病毒肺炎筛查的有效性。
NPJ Digit Med. 2020 Jul 13;3:95. doi: 10.1038/s41746-020-0300-0. eCollection 2020.
8
Analysis of COVID-19 under-reporting in Brazil.巴西新冠肺炎漏报情况分析。
Rev Bras Ter Intensiva. 2020 Jun;32(2):224-228. doi: 10.5935/0103-507x.20200030. Epub 2020 Jun 24.
9
Taste and smell as chemosensory dysfunctions in COVID-19 infection.味觉和嗅觉作为新冠病毒感染中的化学感觉功能障碍
Am J Dent. 2020 Jun;33(3):135-137.
10
COVID-19 and the impact of social determinants of health.2019冠状病毒病与健康的社会决定因素的影响
Lancet Respir Med. 2020 Jul;8(7):659-661. doi: 10.1016/S2213-2600(20)30234-4. Epub 2020 May 18.